CD117 (c-Kit) Monoclonal Antibody (2B8), Brilliant Violet™ 421, eBioscience™, Invitrogen™
Rat Monoclonal Antibody
Manufacturer: Fischer Scientific
The price for this product is unavailable. Please request a quote
Antigen
CD117 (c-Kit)
Concentration
0.2 mg/mL
Classification
Monoclonal
Form
Liquid
Regulatory Status
RUO
Formulation
PBS with BSA and 0.09% sodium azide, pH 7.2
Gene Alias
belly-spot, Bs, CD117, ckit, C-Kit, c-KIT gene1, c-kit protein, c-kit proto-oncogene protein, c-kit receptor, c-kit receptor tyrosine kinase, dominant spotting, Dominant white spotting, Fdc, Gsfsco1, Gsfsco5, Gsfsow3, KIT, kit oncogene, KIT proto-oncogene receptor tyrosine kinase, KIT proto-oncogene, receptor tyrosine kinase, mast cell growth factor receptor, mast/stem cell growth factor receptor, mast/stem cell growth factor receptor Kit, MGF, p145 c-kit, PBT, Piebald trait protein, protein kinase, proto-oncogene c-Kit, proto-oncogene tyrosine-protein kinase Kit, receptor tyrosine kinase c-kit, receptor tyrosine kinase type III, SCFR, SCO1, SCO5, Sl, soluble KIT variant 1, SOW3, spotted sterile male, Ssm, Steel Factor Receptor, Tr-kit, tyrosine kinase receptor, tyrosine kinase receptor c-KIT, tyrosine-protein kinase Kit, v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog, v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene-like protein, W
Gene Symbols
KIT
Primary or Secondary
Primary
Content And Storage
4°, C, store in dark, DO NOT FREEZE!
Clone
2B8
Applications
Flow Cytometry
Conjugate
Brilliant Violet 421
Host Species
Rat
Target Species
Mouse, Porcine
Gene Accession No.
P05532, Q2HWD6
Gene ID (Entrez)
16590, 396810
Isotype
IgG2b κ
Purification Method
Affinity chromatography
Gene
KIT
Related Products
Description
- KIT (c-KIT) is a proto-oncogene and a type 3 transmembrane receptor for MGF (mast cell growth factor, also known as stem cell factor)
- KIT was first identified as the cellular homolog of the feline sarcoma viral oncogene v-kit
- KIT together with its ligand regulates growth and activation of a variety of hemopoietic and non-hemopoietic cells
- Mutations in KIT are associated with gastrointestinal stromal tumors, mast cell disease, acute myelogenous leukemia, and piebaldism
- Recently, deregulation of the KIT receptor TK by the prevalent activation loop mutation D816V has served as a focal point in therapeutic strategies aimed at curbing neoplastic mast cell growth
- c-Kit is expressed in hematopoietic stem cells, germ cells, mast cells and gastrointestinal tract cajal cells
- Upon binding of its ligand stem cell factor (SCF), c-kit dimerizes, resulting in receptor activation and autophosphorylation of various tyrosine residues including tyrosine 703 located on the cytoplasmic domain of the receptor
- This modification allows docking of Grb2 and activation of the Ras/ERK signaling pathway
- SCF/c-kit can activate multiple downstream signaling pathways including PI3K, PLC-gamma and JAK/STAT
- c-kit receptor activation is essential for hematopoiesis, stem cell maintenance and gametogenesis.